{
    "id": "53754529",
    "text": "Panomifene (INN) (former developmental code names GYKI-13504, EGIS-5650) is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group related to tamoxifen that was under development as an antineoplastic agent by Egis Pharmaceuticals and IVAX Drug Research Institute in the 1990s for the treatment of breast cancer but was not marketed.http://adisinsight.springer.com/drugs/800002425 It reached phase II clinical trials before development was terminated. The drug was described in 1981. ==References== ==External links== * Panomifene - AdisInsight Category:Abandoned drugs Category:Primary alcohols Category:Amines Category:Hormonal antineoplastic drugs Category:Trifluoromethyl compounds Category:Selective estrogen receptor modulators Category:Triphenylethylenes ",
    "title": "Panomifene"
}